NASDAQ

COMPASS Pathways Plc - American Depository Shares (CMPS)

599 Thanks from members

COMPASS Pathways (CMPS) displays surging momentum with a 214% annual gain, driven by rolling NDA submissions for COMP360 in treatment-resistant depression, a $433M cash runway, and positive Phase 3 data, though valuation concerns and competitive threats persist.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →